Product How it works Pricing Blog FAQ About Contact
Palisade Bio

Palisade Bio (NASDAQ: PALI) revenue

Palisade Bio reported revenue of $0.0m for fiscal 2025; in fiscal 2024 it was $0.0m.

Palisade Bio's best year of the last 9 was fiscal 2023. The biggest drop was in fiscal 2019, −94.1%.

Revenue, in millions of US dollars0.020160.320170.320180.020190.020200.020220.320230.020240.02025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$0.0m—−$18.1m—
2024$0.0m−100.0%−$14.9m—
2023$0.3m—−$13.1m−4,356.7%
2022$0.0m—−$15.7m—
2020$0.0m−12.2%−$9.3m−68,764.8%
2019$0.0m−94.1%−$8.6m−56,071.8%
2018$0.3m0.0%−$8.3m−3,176.7%
2017$0.3m+1,500.4%−$13.3m−5,118.1%
2016$0.0m—−$20.6m−127,027.2%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Palisade Bio revenue compared with its sector

By revenue for its latest fiscal year, Palisade Bio ranks 413th of the 422 US health care companies with a page on Celsmar.

RankCompanyRevenueRevenue growth
411thNeurogene$0.0m−100.0%
412thNkarta$0.0m—
413thPalisade Bio$0.0m—
414thPraxis Precision Medicines$0.0m−100.0%
415thRocket Pharmaceuticals$0.0m—

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Palisade Bio

How much revenue did Palisade Bio make in fiscal 2025?
Palisade Bio reported revenue of $0.0m for fiscal 2025, compared with $0.0m in fiscal 2024.
What was the best year for revenue at Palisade Bio?
Of its last 9 fiscal years, fiscal 2023, with $0.3m.
Where does Palisade Bio rank in its sector by revenue?
It ranks 413th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Palisade Bio come from?
From the annual report (Form 10-K) that Palisade Bio files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Palisade Bio files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2020 · 2019 · 2018 · 2017 · 2016. More on Palisade Bio: the Palisade Bio page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.